Expression of E-cadherin in squamous cell carcinomas of the cervix with correlations to clinicopathological features

European Journal of Gynaecological Oncology

Volumn 26, Issue 1, 2005, Pages 95-98

  Yaldiz, M ^a   Hakverdi, A U ^a,b   Bayhan, G ^a   Akkus Z ^a  

^a DICLE UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Cervix; E cadherin; Squamous cell carcinoma

Indexed keywords

CELL ADHESION MOLECULE; PARAFFIN; UVOMORULIN;

ARTICLE; CELL JUNCTION; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

CADHERINS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TURKEY; UTERINE CERVICAL NEOPLASMS;

EID: 14644411009     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Yoshida-Noro C., Takeichi M.: "Teratocarcinoma cell adhesion: Identification of a cell-surface protein involved in calcium-dependent cell aggregation". Cell., 1992, 28, 217.
2. Yoshida-Noro C., Suzuki N., Takeichi M.: "Molecular nature of the calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells studied with a monoclonal antibody". Dev. Biol., 1984, 101, 19.
3. Serini G., Trusolino L., Saggiorato O., de Rossi M., Angeli A., Orlandi F., Marchisio P.C.: "Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue". J. Natl. Cancer Inst., 1996, 88, 442.
4. Zhao-Jiang X., Li H., Chen H., Liu-Xue Y., Li Hua Z., Zhang Hua L. et al.: "Expression of e-cadherin and β-catenin in human esophageal squamous cell carcinoma: relationships with prognosis". World J. Gastroenterol., 2003, 9 (2), 225.
5. Siitonen S.M., Kononen J.T., Helin H.J., Rantala I.S., Holli K.A., Isola J.J.: "Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer". Am. J. Clin. Pathol., 1996, 105, 394.
6. Zhou N.Y., Xu P.C., Han B., Li M., Qiuao L., Fang C.D., Yang J.M.: "Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival". World J. Gastroenterol., 2002, 8, 987.
7. Weinel R.J., Neumann K., Kisker O., Rosendahl A.: "Expression and potential role of E-cadherin in pancreatic carcinoma". Int. J. Pancreatol., 1996, 19, 25.
8. Wakatsuki S., Watanabe R., Saito K., Katagiri A., Sato S., Tomito Y.: "Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder cancer". Cancer Lett., 1996, 103, 11.
9. Cheng L., Nagabhushan M., Pretlow T.B., Amini S.B., Pretlow T.G.: "Expression of E-cadherin in primary and metastatic prostate cancer". Am. J. Pathol., 1996, 148, 1375.
10. Danen E.H., Vries T.J., Morandini R., Ghanen G.G., Ruiter D.J., van Muijen G.N.: "E-cadherin expression in human melanoma. Melanoma Res., 1996, 6, 127.
11. Tohma Y., Yamashima T., Yamashita J.: "Immunohistochemical localization of cell adhesion molecule epithelial cadherin in human aracnoid villi and menimgioma". Cancer Res., 1992, 52, 1981.
12. Saguragi N., Nishiya M., Ikeda K., Ohkouch T., Furth E.E., Hareyma H., Satoh C., Fujimato S.: "Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion". Gynecol. Oncol., 1994, 53, 183.
13. Inoue M., Ogawa H., Miyata M., Shiozaki H., Tanizawa O.: "Expression of E-cadherin in normal, benign and malignant tissue of female genital organs". Am. J. Clin. Pathol., 1995, 176, 151.
14. Vessey C.J., Wilding J., Folarin N., Hirano S., Takeichi M., Soutter P. et al.: "Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma". J. Pathol., 1995, 176, 151.
15. Veath A.L., Carson L.F., Ramakrishan S.: "Differantial expression of the cell-cell adhesion molecule E-cadherin in asicites and solid human ovarian tumor cells". Int. J. Cancer, 1994, 58, 393.
16. Kase S., Sugio K., Yamazaki K., Okamoto T., Yano T., Sugimachi K.: "Expression of E-cadherin and β-catenin in human non-small cell lung cancer and clinical significance". Clin. Cancer Res., 2000, 6, 4789.
17. Pignatelli M., Vessey C.J.: "Adhesion molecules: Novel moleculer tools in tumour pathology". Human. Pathol., 1994, 25, 849.
18. Pignatelli M.: "E-cadherin: A biological marker of tumour differentiation". J. Pathol., 1993, 171, 81.
19. Frixen U.H., Behren J., Sachs M., Eberle G., Voss B., Warda A.: "E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells". J. Cell. Biol., 1991, 113, 173.
20. Bukholm I.K., Nesland J.M., Karesen R., Jacobsen U., Borresen Dale A.L.: "E-cadherin and alpha-, beta-,and gamma-catenin protein expression in relation to metastasis in human breast carcinoma". J. Pathol., 1998, 185, 262.
21. De Marzo A.M., Knudsen B., Chan-Tack K., Ebstain J.I.: "E-cadherin expression as a marker of tumor aggresiveness in routinely processed radical prostatectomy specimens". Urology, 1999, 53, 707.
22. Tamura S., Shiozaki H., Miyata M. et al.: "Decreased E-cadherin expression is associated with hematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the esophagus". Br. J. Surg., 1996, 83, 1608.
23. Charpin C., Garcia S., Bonnier P. et al.: "Reduced E-cadherin immunohistochemical expression in node-negative breast carcinoma correlates with 10-year survival". Am. J. Clin. Pathol., 1998, 109, 431.
24. Honds S.: "Immunohistochemical study on the expression of E-cadherin in normal tissue and squamous cell carcinoma of the uterina cervix". Nippon Sanka Fujinka Gakkai Zasshi, 1992, 44, 517.
25. Koseki S., Aoki T., Ansai S., Hozumi Y., Mitsuhashi Y., Kondo S.: "An immunohistochemical study of E-cadherin expression in human squamous cell carcinoma of the skin: relationship between decreased expression of E-cadherin in the primary lesion and regional lymph node metastasis". J. Dermatol., 1999, 26, 416.
26. Zheng Z., Pan J., Chu B., Wong Y.C., Cheung L.A., Tsao S.W.: "Down regulation and abnormal expression of E-cadherin and β-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis". Hum. Pathol., 1999, 30, 458.
27. Rodrigo J.P., Dominguez F., Alvarez C., Manrique C., Herrero A., Suarez C.: "Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features". Eur. J. Cancer, 2002, 38, 1059.